FDA Approves Veklury (remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis

FOSTER CITY, Calif.--(BUSINESS WIRE) July 14, 2023 -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) for the use of Veklury® (remdesivir)...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news